- HMNC Brain Health raises $50M Series B to advance two depression drugsHMNC Brain Health has secured $50 million in a Series B fundraise designed to support two psychiatry programs into mid-stage studies. The family-owned German drugmaker Medice led the Series B, wh…Endpoints · 1mo ago↗ source
- STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetesThe FDA has approved a drug that was previously caught in a dispute between career staff and the political appointee head of the CDER.STAT · 1mo ago↗ source
- WHO director-general is profoundly concerned after visit to Ebola outbreak areaThe director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DRC, he told STAT in an interview.